Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1186/1750-1326-8-2.

Title:
Neuron loss in the 5XFAD mouse model of Alzheimer’s disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation | Molecular Neurodegeneration
Description:
Background Although the mechanism of neuron loss in Alzheimer’s disease (AD) is enigmatic, it is associated with cerebral accumulation of Aβ42. The 5XFAD mouse model of amyloid deposition expresses five familial AD (FAD) mutations that are additive in driving Aβ42 overproduction. 5XFAD mice exhibit intraneuronal Aβ42 accumulation at 1.5 months, amyloid deposition at 2 months, and memory deficits by 4 months of age. Results Here, we demonstrate by unbiased stereology that statistically significant neuron loss occurs by 9 months of age in 5XFAD mice. We validated two Aβ42-selective antibodies by immunostaining 5XFAD; BACE1−/− bigenic brain sections and then used these antibodies to show that intraneuronal Aβ42 and amyloid deposition develop in the same regions where neuron loss is observed in 5XFAD brain. In 5XFAD neuronal soma, intraneuronal Aβ42 accumulates in puncta that co-label for Transferrin receptor and LAMP-1, indicating endosomal and lysosomal localization, respectively. In addition, in young 5XFAD brains, we observed activated Caspase-3 in the soma and proximal dendrites of intraneuronal Aβ42-labeled neurons. In older 5XFAD brains, we found activated Caspase-3-positive punctate accumulations that co-localize with the neuronal marker class III β-tubulin, suggesting neuron loss by apoptosis. Conclusions Together, our results indicate a temporal sequence of intraneuronal Aβ42 accumulation, Caspase-3 activation, and neuron loss that implies a potential apoptotic mechanism of neuron death in the 5XFAD mouse.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Health & Fitness
  • Cryptocurrency
  • Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

xfad, mice, neuron, intraneuronal, loss, pubmed, caspase, neurons, article, months, sections, figure, google, scholar, activated, cas, layer, brain, amyloid, app, alzheimers, disease, mouse, age, bace, cortex, subiculum, antibody, model, neuronal, transgenic, pyramidal, accumulation, activation, central, nontransgenic, large, observed, puncta, plaque, results, soma, death, significant, apoptosis, plaques, staining, abeta, deposition, exhibit,

Topics {✒️}

aβ42 c-terminal neo-epitope membrane-bound subcellular compartments app c-terminal fragments article download pdf neuronal markers β-tubulin cathepsin-d-positive puncta identifies aβ42-positive plaque activated caspse-3-positive accumulations 42-residue amyloid beta-protein terminal neo-epitope amyloid-beta plaque formation rabbit monoclonal anti-aβ42 intraneuronal aβ42-positive puncta punctate aβ42-positive staining activated caspase-3-positive ring mouse monoclonal anti-aβ42 activated caspase-3-positive puncta rat monoclonal anti-lamp1 recognize full-length app intracellular amyloid-beta accumulation design-based unbiased stereology intraneuronal beta-amyloid accumulation activated caspase-3-positive aggregates intraneuronal beta-amyloid aggregates endosomal-lysosomal pathway leads selective anti-aβ42 antibody anti-aβ42-selective antibody anti-aβ42 selective antibody amyloid deposition develop intraneuronal aβ42-labeled neurons anti-aβ42-selective antibodies neo-epitope generated full size image amyloid precursor protein st george hyslop central early role caspase-3-positive proximal dendrites display neuron loss amyloid plaque formation exhibit neuron loss eclipse 80i microscope neurodegenerative processes relevant sci transl med aging ps/app mice display intraneuronal aβ42 privacy choices/manage cookies amyloid deposition expresses exhibit intraneuronal aβ42 caspase-3-positive puncta caspase-3 positive puncta

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Neuron loss in the 5XFAD mouse model of Alzheimer’s disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation
         description:Although the mechanism of neuron loss in Alzheimer’s disease (AD) is enigmatic, it is associated with cerebral accumulation of Aβ42. The 5XFAD mouse model of amyloid deposition expresses five familial AD (FAD) mutations that are additive in driving Aβ42 overproduction. 5XFAD mice exhibit intraneuronal Aβ42 accumulation at 1.5 months, amyloid deposition at 2 months, and memory deficits by 4 months of age. Here, we demonstrate by unbiased stereology that statistically significant neuron loss occurs by 9 months of age in 5XFAD mice. We validated two Aβ42-selective antibodies by immunostaining 5XFAD; BACE1−/− bigenic brain sections and then used these antibodies to show that intraneuronal Aβ42 and amyloid deposition develop in the same regions where neuron loss is observed in 5XFAD brain. In 5XFAD neuronal soma, intraneuronal Aβ42 accumulates in puncta that co-label for Transferrin receptor and LAMP-1, indicating endosomal and lysosomal localization, respectively. In addition, in young 5XFAD brains, we observed activated Caspase-3 in the soma and proximal dendrites of intraneuronal Aβ42-labeled neurons. In older 5XFAD brains, we found activated Caspase-3-positive punctate accumulations that co-localize with the neuronal marker class III β-tubulin, suggesting neuron loss by apoptosis. Together, our results indicate a temporal sequence of intraneuronal Aβ42 accumulation, Caspase-3 activation, and neuron loss that implies a potential apoptotic mechanism of neuron death in the 5XFAD mouse.
         datePublished:2013-01-14T00:00:00Z
         dateModified:2013-01-14T00:00:00Z
         pageStart:1
         pageEnd:12
         license:http://creativecommons.org/licenses/by/2.0
         sameAs:https://doi.org/10.1186/1750-1326-8-2
         keywords:
            Intraneuronal Aβ42
            5XFAD
            Alzheimer’s disease
            Amyloid-β
            Caspase-3
            Neuron loss
            Apoptosis
            Neurosciences
            Neurology
            Molecular Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1750-1326-8-2/MediaObjects/13024_2012_Article_380_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1750-1326-8-2/MediaObjects/13024_2012_Article_380_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1750-1326-8-2/MediaObjects/13024_2012_Article_380_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1750-1326-8-2/MediaObjects/13024_2012_Article_380_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1750-1326-8-2/MediaObjects/13024_2012_Article_380_Fig5_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1750-1326-8-2/MediaObjects/13024_2012_Article_380_Fig6_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1750-1326-8-2/MediaObjects/13024_2012_Article_380_Fig7_HTML.jpg
         isPartOf:
            name:Molecular Neurodegeneration
            issn:
               1750-1326
            volumeNumber:8
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:William A Eimer
               affiliation:
                     name:Northwestern University
                     address:
                        name:Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Robert Vassar
               affiliation:
                     name:Northwestern University
                     address:
                        name:Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Neuron loss in the 5XFAD mouse model of Alzheimer’s disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation
      description:Although the mechanism of neuron loss in Alzheimer’s disease (AD) is enigmatic, it is associated with cerebral accumulation of Aβ42. The 5XFAD mouse model of amyloid deposition expresses five familial AD (FAD) mutations that are additive in driving Aβ42 overproduction. 5XFAD mice exhibit intraneuronal Aβ42 accumulation at 1.5 months, amyloid deposition at 2 months, and memory deficits by 4 months of age. Here, we demonstrate by unbiased stereology that statistically significant neuron loss occurs by 9 months of age in 5XFAD mice. We validated two Aβ42-selective antibodies by immunostaining 5XFAD; BACE1−/− bigenic brain sections and then used these antibodies to show that intraneuronal Aβ42 and amyloid deposition develop in the same regions where neuron loss is observed in 5XFAD brain. In 5XFAD neuronal soma, intraneuronal Aβ42 accumulates in puncta that co-label for Transferrin receptor and LAMP-1, indicating endosomal and lysosomal localization, respectively. In addition, in young 5XFAD brains, we observed activated Caspase-3 in the soma and proximal dendrites of intraneuronal Aβ42-labeled neurons. In older 5XFAD brains, we found activated Caspase-3-positive punctate accumulations that co-localize with the neuronal marker class III β-tubulin, suggesting neuron loss by apoptosis. Together, our results indicate a temporal sequence of intraneuronal Aβ42 accumulation, Caspase-3 activation, and neuron loss that implies a potential apoptotic mechanism of neuron death in the 5XFAD mouse.
      datePublished:2013-01-14T00:00:00Z
      dateModified:2013-01-14T00:00:00Z
      pageStart:1
      pageEnd:12
      license:http://creativecommons.org/licenses/by/2.0
      sameAs:https://doi.org/10.1186/1750-1326-8-2
      keywords:
         Intraneuronal Aβ42
         5XFAD
         Alzheimer’s disease
         Amyloid-β
         Caspase-3
         Neuron loss
         Apoptosis
         Neurosciences
         Neurology
         Molecular Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1750-1326-8-2/MediaObjects/13024_2012_Article_380_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1750-1326-8-2/MediaObjects/13024_2012_Article_380_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1750-1326-8-2/MediaObjects/13024_2012_Article_380_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1750-1326-8-2/MediaObjects/13024_2012_Article_380_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1750-1326-8-2/MediaObjects/13024_2012_Article_380_Fig5_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1750-1326-8-2/MediaObjects/13024_2012_Article_380_Fig6_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1750-1326-8-2/MediaObjects/13024_2012_Article_380_Fig7_HTML.jpg
      isPartOf:
         name:Molecular Neurodegeneration
         issn:
            1750-1326
         volumeNumber:8
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:William A Eimer
            affiliation:
                  name:Northwestern University
                  address:
                     name:Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Robert Vassar
            affiliation:
                  name:Northwestern University
                  address:
                     name:Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Molecular Neurodegeneration
      issn:
         1750-1326
      volumeNumber:8
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Northwestern University
      address:
         name:Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, USA
         type:PostalAddress
      name:Northwestern University
      address:
         name:Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:William A Eimer
      affiliation:
            name:Northwestern University
            address:
               name:Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, USA
               type:PostalAddress
            type:Organization
      name:Robert Vassar
      affiliation:
            name:Northwestern University
            address:
               name:Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, USA
      name:Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, USA

External Links {🔗}(193)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.3s.